How Much? Gilead Will Charge $900 for Sovaldi in India – Pharmalot – WSJ
1
India has become the latest country where the Sovaldi hepatitis C treatment will be offered for $900 per patient. The move, which was reported by The Times of India, comes a few weeks after the manufacturer, Gilead Sciences , is making the medication available for the same price in Egypt.
The pricing reflects an effort by Gilead to…
via How Much? Gilead Will Charge $900 for Sovaldi in India – Pharmalot – WSJ.
One thought on “How Much? Gilead Will Charge $900 for Sovaldi in India – Pharmalot – WSJ”
Leave a Reply
You must be logged in to post a comment.
India’s medical tourism industry could be getting a big boost from this…